Xstim earns FDA nod for spinal fusion stimulator

Xstim earned FDA premarket application approval for its spine fusion stimulator, the company said April 16.

Advertisement

The Xstim device uses a low-energy signal to promote bone healing after spinal fusions, according to a news release. It is noninvasive and designed to streamline patient therapy management.

The device is expected to hit the market in the second quarter.

Advertisement

Next Up in Spinal Tech

  • The highest-paid CFO of orthopedic medtech companies in the U.S. saw more than $12 million per year in total compensation…

  • Spinal device company Alphatec has commercially launched its Prone TransPsoas corpectomy system.  The launch marks the expansion of Alphatec’s deformity…

Advertisement

Comments are closed.